TDGF1 Produkte
(Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte TDGF1 Kategorien
TDGF1 Antikörper
High quality antibodies with extensive validation data.
TDGF1 ELISA Kits
Reliable ELISA kits for a wide range of species.
TDGF1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene TDGF1 Antikörper
- (5)
- (3)
- (2)
Empfohlene TDGF1 ELISA Kits
- (1)
- (1)
- (1)
Empfohlene TDGF1 Proteine
- (1)
- (1)
Neueste Publikationen zu unseren TDGF1 Produkten
: "An evaluation of different Cripto-1 antibodies and their variable results." in: Journal of cellular biochemistry, (2019) (PubMed).: "MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression." in: Molecular medicine reports, Vol. 13, Issue 6, pp. 4897-903, (2016) (PubMed).
: "Cripto-1 vaccination elicits protective immunity against metastatic melanoma." in: Oncoimmunology, Vol. 5, Issue 5, pp. e1128613, (2016) (PubMed).
: "Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi." in: Oncology letters, Vol. 12, Issue 2, pp. 1349-1354, (2016) (PubMed).
: "GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer." in: Cancer research and treatment : official journal of Korean Cancer Association, Vol. 47, Issue 4, pp. 804-12, (2015) (PubMed).
: "Autoregulation and heterogeneity in expression of human Cripto-1." in: PLoS ONE, Vol. 10, Issue 2, pp. e0116748, (2015) (PubMed).
: "Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways." in: Journal of the neurological sciences, Vol. 347, Issue 1-2, pp. 137-42, (2014) (PubMed).
: "Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients." in: Translational oncology, Vol. 6, Issue 6, pp. 732-41, (2014) (PubMed).
: "The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics." in: Cell cycle (Georgetown, Tex.), Vol. 12, Issue 9, pp. 1450-6, (2013) (PubMed).
: "Cancer hallmarks in induced pluripotent cells: new insights." in: Journal of cellular physiology, Vol. 225, Issue 2, pp. 390-3, (2010) (PubMed).
Synonyme und alternative Namen zu TDGF1
teratocarcinoma-derived growth factor 1 (TDGF1), teratocarcinoma-derived growth factor 1 (Tdgf1), teratocarcinoma-derived growth factor 1 (tdgf1), teratocarcinoma-derived growth factor 1, member 3 L homeolog (tdgf1.3.L), teratocarcinoma-derived growth factor 1, member 1 (tdgf1.1), cb85, CR, CR1, cr1, cr1a, CRGF, CRIPTO, cripto, Cripto-1, cripto-3, frl-1, frl1, tdgf1, TDGF1, tdgf3, wu:fe01d04, xcr1, zgc:109829Bezeichner auf Proteinebene für TDGF1
- cripto-1 growth factor
- epidermal growth factor-like cripto protein CR1
- TERATOCARCINOMA-DERIVED GROWTH FACTOR PRECURSOR (EPIDERMAL GROWTH FACTOR-LIKE CRIPTO PROTEIN) (CRIPTO GROWTH FACTOR)
- cripto growth factor
- epidermal growth factor-like Cripto protein
- teratocarcinoma-derived growth factor
- cryptic protein
- one eyed pinhead
- teratocarcinoma-derived growth factor 1
- cripto-1a
- fibroblast growth factor receptor ligand 1
- teratocarcinoma-derived growth factor 3